|
⚲
|
| Keyboard |
| Roy Freeman | |
|---|---|
| Firm | |
| Address | c/o Inhibikase Therapeutics, Inc 3350 Riverwood Parkway Se, Suite 1900 Atlanta, GA 30339 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Inhibikase Therapeutics Inc | 021-515107 | Director | of 8.0 M |
||
| CND Life Sciences Inc | 021-420670 | Director | 4.2 M of 5.0 M |
||
| CND Life Sciences Inc | 021-386767 | Director | 2.9 M of 2.9 M |
||
| Serpent Private Equity LP | 021-251728 | Executive Officer | of 21.00 B |
||
| Serpent Venture Capital LP | 021-251734 | Executive Officer | of 7,000.0 M |
||